Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: An exploratory study of clinical heterogeneity
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 23 (6) , 560-574
- https://doi.org/10.1016/0006-3223(88)90003-0
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patientsLife Sciences, 1985
- Urinary MHPG Excretion and Treatment with Desipramine or AmitriptylineJournal of Clinical Psychopharmacology, 1983
- Diurnal variation of urinary MHPG in unipolar and bipolar depressivesActa Psychiatrica Scandinavica, 1982
- Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatmentPsychological Medicine, 1982
- High-Affinity3H-lmipramine Binding: A new Biological Marker in DepressionPharmacopsychiatry, 1982
- High-affinity 3H-imipramine binding: a new biological tool for studies in depressionTrends in Neurosciences, 1981
- High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteersPsychopharmacology, 1981
- High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disordersLife Sciences, 1981
- Tritiated Imipramine Binding Sites Are Decreased in Platelets of Untreated Depressed PatientsScience, 1980
- States of DepressionBMJ, 1938